• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how does medication for adhd work long-term exposure may affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the advantages of using them against the risks to the fetus. Physicians do not have the necessary data to make unequivocal recommendations but they can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers used a vast population-based study of case-control to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure correct case classification and to minimize the chance of bias.

However, the study had its limitations. Most important, they were unable to distinguish the effects of the medication from those of the underlying disorder. This limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or the confounding effect of comorbidities. The researchers also did not study the long-term effects for the offspring.

The study showed that babies whose mothers took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that can lessen the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or end treatment during pregnancy is a question that doctors are having to confront. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what medication is prescribed for adhd they know, the experiences of other doctors, and what the research says on the topic as well as their own best judgment for each patient.

Particularly, the issue of possible risks to the infant can be difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are conflicting. Most studies restrict their analysis to live births, which may underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects However, other studies haven't established a link. most popular adhd medication studies have shown that there is a neutral, or slight negative impact. In each case an in-depth study of the potential risks and benefits must be performed.

For many women with ADHD and ADD, the decision to stop taking medication can be difficult, if not impossible. In an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd medication not working medication during pregnancy can increase depression, feelings of isolation and family conflict for patients with ADHD. In addition, a decrease in medication can affect the ability to do jobs and drive safely, which are important aspects of daily life for a lot of people with ADHD.

She suggests that women who are unsure whether to take the medication or stop due to pregnancy should educate family members, coworkers and acquaintances about the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. It can also help a woman feel more confident in her decision. Some medications can pass through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the medication could be transferred to the baby.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns over the impact that these drugs could have on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two massive data sets to study over 4.3 million pregnancy and determine whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medications was linked to an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study didn't find any association between early medication usage and other congenital anomalies such as facial deformities or club feet. The results are in line with previous studies showing an increase, but not significant, in the risk of heart malformations among women who began taking ADHD medications before the birth of their child. The risk increased in the latter stages of pregnancy when many women decided to stop taking their medication.

Women who took ADHD medications during the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby who needed help breathing at birth. The researchers of the study were not able to remove bias in selection since they restricted the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they encounter pregnant women. They suggest that although discussing the risks and benefits is crucial but the decision to stop or keep treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to think about, it isn't advised due to the high rate depression and other mental disorders among women who are pregnant or have recently given birth. Further, the research suggests that women who choose to stop taking their medication are more likely to have difficulties adjusting to life without them after the baby's arrival.

Nursing

It can be a stressful experience to become a mother. Women with adhd medication and pregnancy uk are often faced with a number of difficulties when they have to manage their symptoms, go to doctor best Over the counter adhd medication for adults appointments and prepare for the birth of a baby and adjust to new routines. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to a nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. However, the rate of exposure to medications by the newborn can vary depending on dosage, how often it is administered, and the time of day it is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't fully known.

Because of the lack of research, some physicians might be tempted to stop taking stimulant drugs during the pregnancy of a woman. This is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the risk to the embryo. Until more information becomes available, doctors may inquire about pregnant patients if they have any background of ADHD or if they are planning to take medication in the perinatal period.

Numerous studies have demonstrated that women can continue to take their adhd medication pregnancy (Related Web Page) medication safely while breastfeeding and during pregnancy. As a result, many patients choose to do so, and after consulting with their doctor, they have discovered that the benefits of continuing their current medication far outweigh any risks.

It is essential for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and build strategies for coping. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if needed, adjustments to the medication regimen.